Steve Schonfeld’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Steve Schonfeld's REGN Position: Q2 2026 in Review
Steve Schonfeld opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 4,759 shares worth $2.97M. The stake represents 0.01% of the portfolio and ranks #869 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in REGN as recently as Q3 2025.
Steve Schonfeld first reported a position in REGN in Q4 2016 and has held it in 27 quarters since. The position peaked at $15.9M in Q4 2024. 1,328 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Steve Schonfeld held 4,759 shares of Regeneron Pharmaceuticals worth $2.97M as of Q2 2026.
- Regeneron Pharmaceuticals was a new Steve Schonfeld position in Q2 2026.
- Regeneron Pharmaceuticals made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #869 holding.
- Steve Schonfeld first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 27 quarters since.
- Steve Schonfeld's Regeneron Pharmaceuticals position peaked at $15.9M in Q4 2024.
- 1,328 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.